Aqr Capital Management LLC Dexcom Inc Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 197,295 shares of DXCM stock, worth $15.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
197,295
Previous 85,017 132.07%
Holding current value
$15.8 Million
Previous $9.64 Million 37.17%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$64.0 - $116.06 $7.19 Million - $13 Million
112,278 Added 132.07%
197,295 $13.2 Million
Q2 2024

Aug 14, 2024
SELL
$110.31 - $140.45 $13.1 Million - $16.7 Million
-118,657 Reduced 58.26%
85,017 $9.64 Million
Q1 2024

May 15, 2024
BUY
$114.22 - $140.1 $8.11 Million - $9.94 Million
70,964 Added 53.47%
203,674 $28.2 Million
Q4 2023

Feb 14, 2024
BUY
$75.49 - $124.16 $6.55 Million - $10.8 Million
86,717 Added 188.54%
132,710 $16.5 Million
Q3 2023

Nov 14, 2023
SELL
$86.06 - $137.93 $4.57 Million - $7.32 Million
-53,099 Reduced 53.59%
45,993 $4.29 Million
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $4.38 Million - $5.1 Million
38,973 Added 64.83%
99,092 $12.7 Million
Q1 2023

May 15, 2023
BUY
$104.0 - $122.92 $854,672 - $1.01 Million
8,218 Added 15.83%
60,119 $6.98 Million
Q4 2022

Feb 14, 2023
SELL
$84.98 - $122.67 $2.05 Million - $2.96 Million
-24,136 Reduced 31.74%
51,901 $5.88 Million
Q3 2022

Nov 14, 2022
BUY
$76.35 - $94.18 $2.07 Million - $2.55 Million
27,066 Added 55.27%
76,037 $6.12 Million
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $2.64 Million - $5.17 Million
38,886 Added 385.58%
48,971 $3.64 Million
Q1 2022

May 16, 2022
BUY
$94.08 - $130.2 $252,981 - $350,107
2,689 Added 36.36%
10,085 $5.16 Million
Q4 2021

Feb 14, 2022
BUY
$129.87 - $162.82 $129 - $162
1 Added 0.01%
7,396 $3.97 Million
Q3 2021

Nov 15, 2021
SELL
$106.71 - $143.18 $213 - $286
-2 Reduced 0.03%
7,395 $4.04 Million
Q2 2021

Aug 16, 2021
SELL
$80.99 - $107.93 $106,339 - $141,712
-1,313 Reduced 15.07%
7,397 $3.15 Million
Q1 2021

May 17, 2021
SELL
$84.79 - $104.74 $554,017 - $684,371
-6,534 Reduced 42.86%
8,710 $3.09 Million
Q4 2020

Feb 16, 2021
SELL
$78.0 - $104.5 $87,516 - $117,249
-1,122 Reduced 6.86%
15,244 $5.55 Million
Q3 2020

Nov 16, 2020
BUY
$95.51 - $112.95 $293,502 - $347,095
3,073 Added 23.12%
16,366 $6.59 Million
Q2 2020

Aug 17, 2020
BUY
$62.68 - $105.34 $16,234 - $27,283
259 Added 1.99%
13,293 $5.27 Million
Q1 2020

May 15, 2020
BUY
$47.79 - $75.63 $184,899 - $292,612
3,869 Added 42.21%
13,034 $3.51 Million
Q4 2019

Feb 14, 2020
SELL
$36.62 - $57.29 $170,026 - $265,997
-4,643 Reduced 33.63%
9,165 $2.01 Million
Q3 2019

Nov 14, 2019
SELL
$35.53 - $43.8 $3.12 Million - $3.85 Million
-87,909 Reduced 86.43%
13,808 $2.05 Million
Q2 2019

Aug 14, 2019
SELL
$27.84 - $38.92 $11.1 Million - $15.5 Million
-398,353 Reduced 79.66%
101,717 $15.2 Million
Q1 2019

May 14, 2019
BUY
$28.07 - $38.18 $3.53 Million - $4.8 Million
125,704 Added 33.58%
500,070 $59.2 Million
Q4 2018

Feb 14, 2019
BUY
$26.99 - $37.37 $6.26 Million - $8.67 Million
232,055 Added 163.06%
374,366 $44.8 Million
Q3 2018

Nov 15, 2018
BUY
$23.35 - $36.72 $2.76 Million - $4.33 Million
118,033 Added 486.17%
142,311 $20.4 Million
Q2 2018

Aug 14, 2018
SELL
$17.54 - $25.22 $49,217 - $70,767
-2,806 Reduced 10.36%
24,278 $2.31 Million
Q1 2018

May 15, 2018
SELL
$13.06 - $18.54 $456,068 - $647,435
-34,921 Reduced 56.32%
27,084 $2.01 Million
Q4 2017

Feb 14, 2018
SELL
$11.12 - $15.38 $407,181 - $563,169
-36,617 Reduced 37.13%
62,005 $3.56 Million
Q3 2017

Nov 14, 2017
BUY
$11.36 - $18.98 $1.12 Million - $1.87 Million
98,622
98,622 $4.83 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email